Article
Quantitative assay for the detection of the V617F variant in the Janus kinase 2 (JAK2) gene using the Luminex xMAP technology.
BMC medical genetics - 1 Apr 2010
Paradis François W, Simard Raynald, Gaudet Daniel
Abstract excerpt
BACKGROUND: The availability of clinically valid biomarkers contribute to improve the diagnosis and clinical management of diseases. A valine-to-phenylalanine substitution at position 617 (V617F) in the Janus kinase 2 (JAK2) gene has been recently associated with key signaling abnormalities in the transduction of haemopoietic growth-factor receptors and is now considered as a useful clinical marker of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
